OP29 Tofacitinib in ulcerative colitis: Real-world evidence from Eneida Registry

MLA

Jordina Llaó, et al. “OP29 Tofacitinib in Ulcerative Colitis: Real-World Evidence from Eneida Registry.” Journal of Crohn’s and Colitis, vol. 14, Jan. 2020, pp. S026–28. EBSCOhost, https://doi.org/10.1093/ecco-jcc/jjz203.028.

APA

Jordina Llaó, Ana Garre, Olga Merino-Ochoa, Alfredo J. Lucendo, Javier P. Gisbert, David Busquets, M Boscá-Watts, A López Sanromán, C González-Muñoza, Isabel Vera-Mendoza, Agnès Fernández-Clotet, Daniel Ginard, C Rodríguez, J Martínez-Cadilla, Teresa Torrano Martínez, Monica Sierra-Ausin, M Piqueras, Ana Yaiza Carbajo, Saioa Rubio, … F Bermejo. (2020). OP29 Tofacitinib in ulcerative colitis: Real-world evidence from Eneida Registry. Journal of Crohn’s and Colitis, 14, S026–S028. https://doi.org/10.1093/ecco-jcc/jjz203.028

Chicago

Jordina Llaó, Ana Garre, Olga Merino-Ochoa, Alfredo J. Lucendo, Javier P. Gisbert, David Busquets, M Boscá-Watts, et al. 2020. “OP29 Tofacitinib in Ulcerative Colitis: Real-World Evidence from Eneida Registry.” Journal of Crohn’s and Colitis 14 (January): S026–028. doi:10.1093/ecco-jcc/jjz203.028.